Slingshot members are tracking this event:

APD334 (Etrasimod) in treating Ulcerative colitis Phase 2 data due Q1 2018

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
ARNA Community voting in process

Additional Information

Additional Relevant Details Data previously expected 4Q 2016.
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Ulcerative Colitis, Apd334